Melatonin as a candidate compound for neuroprotection in amyotrophic lateral sclerosis (ALS): high tolerability of daily oral melatonin administration in ALS patients
2002 | journal article
Jump to: Cite & Linked | Documents & Media | Details | Version history
Cite this publication
Melatonin as a candidate compound for neuroprotection in amyotrophic lateral sclerosis (ALS): high tolerability of daily oral melatonin administration in ALS patients
Jacob, S. ; Poeggeler, B. ; Weishaupt, J. H. ; Sirén, A.-L. ; Hardeland, R. ; Bähr, M. & Ehrenreich, H. (2002)
Journal of Pineal Research, 33(3) pp. 186-187. DOI: https://doi.org/10.1034/j.1600-079X.2002.02943.x
